FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094508051> ?p ?o ?g. }

• W3094508051 endingPage "154409" @default.
• W3094508051 startingPage "154409" @default.
• W3094508051 abstract "Background and objectives The gut–liver axis plays an important role in the pathogenesis of nonalcoholic steatohepatitis (NASH), and increased intestinal permeability causes transfer of endotoxin to the liver, which activates the immune response, ultimately leading to hepatic inflammation. Nuclear receptor Rev-erbα is a critical regulator of circadian rhythm, cellular metabolism, and inflammatory responses. However, the role and mechanism of Rev-erbα in gut barrier function and NASH remain unclear. In the present study, we investigated the involvement of Rev-erbα in the regulation of intestinal permeability and the treatment of NASH. Methods and results The expression of tight junction-related genes and Rev-erbs decreased in the jejunum, ileum and colon of mice with high cholesterol, high fat diet (CL)-induced NASH. Chromatin immunoprecipitation analysis indicated that REV-ERBα directly bound to the promoters of tight junction genes to regulate intestinal permeability. Pharmacological activation of REV-ERBα by SR9009 protected against lipopolysaccharide-induced increased intestinal permeability both in vitro and in vivo, and these effects were associated with the activation of autophagy and decreased apoptotic signaling of epithelial cells. In addition, the chronopharmacological effects of SR9009 were more potent at Zeitgeber time 0 (ZT0) than at ZT12, which was contrary to the rhythm of Rev-erbs in the gastrointestinal tract. The administration of SR9009 attenuated hepatic lipid accumulation, insulin resistance, inflammation, and fibrosis in mice with CL diet-induced NASH, which might be partly attributed to the enhancement of intestinal barrier function. Conclusion Chronopharmacological activation of REV-ERBα might be a potential strategy to treat intestinal barrier dysfunction-related disorders and NASH." @default.
• W3094508051 created "2020-10-29" @default.
• W3094508051 creator A5012833454 @default.
• W3094508051 creator A5017845479 @default.
• W3094508051 creator A5031700781 @default.
• W3094508051 creator A5061597284 @default.
• W3094508051 creator A5070892221 @default.
• W3094508051 creator A5085416114 @default.
• W3094508051 date "2021-01-01" @default.
• W3094508051 modified "2023-10-06" @default.
• W3094508051 title "Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeability" @default.
• W3094508051 cites W1484320536 @default.
• W3094508051 cites W1597830790 @default.
• W3094508051 cites W1964552652 @default.
• W3094508051 cites W1968444524 @default.
• W3094508051 cites W1971896370 @default.
• W3094508051 cites W1973826653 @default.
• W3094508051 cites W1975191711 @default.
• W3094508051 cites W1983841082 @default.
• W3094508051 cites W1985333297 @default.
• W3094508051 cites W1987769185 @default.
• W3094508051 cites W1990356462 @default.
• W3094508051 cites W1991594587 @default.
• W3094508051 cites W2011072921 @default.
• W3094508051 cites W2014677321 @default.
• W3094508051 cites W2015668060 @default.
• W3094508051 cites W2016924160 @default.
• W3094508051 cites W2017730825 @default.
• W3094508051 cites W2023831182 @default.
• W3094508051 cites W2030407395 @default.
• W3094508051 cites W2035618305 @default.
• W3094508051 cites W2036275511 @default.
• W3094508051 cites W2051984731 @default.
• W3094508051 cites W2052930713 @default.
• W3094508051 cites W2073229191 @default.
• W3094508051 cites W2097715943 @default.
• W3094508051 cites W2104290916 @default.
• W3094508051 cites W2114602866 @default.
• W3094508051 cites W2117131162 @default.
• W3094508051 cites W2120805022 @default.
• W3094508051 cites W2125158282 @default.
• W3094508051 cites W2127010382 @default.
• W3094508051 cites W2144856600 @default.
• W3094508051 cites W2158616514 @default.
• W3094508051 cites W2159992457 @default.
• W3094508051 cites W2169300857 @default.
• W3094508051 cites W2211097356 @default.
• W3094508051 cites W2286598790 @default.
• W3094508051 cites W2323937300 @default.
• W3094508051 cites W2419095158 @default.
• W3094508051 cites W2463324070 @default.
• W3094508051 cites W2777780841 @default.
• W3094508051 cites W2783204408 @default.
• W3094508051 cites W2897092735 @default.
• W3094508051 cites W2940575348 @default.
• W3094508051 cites W2945672034 @default.
• W3094508051 cites W2967786139 @default.
• W3094508051 cites W2969326780 @default.
• W3094508051 cites W2990265167 @default.
• W3094508051 cites W2995400873 @default.
• W3094508051 cites W2998658597 @default.
• W3094508051 cites W3015382920 @default.
• W3094508051 cites W3046783547 @default.
• W3094508051 doi "https://doi.org/10.1016/j.metabol.2020.154409" @default.
• W3094508051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33096076" @default.
• W3094508051 hasPublicationYear "2021" @default.
• W3094508051 type Work @default.
• W3094508051 sameAs 3094508051 @default.
• W3094508051 citedByCount "18" @default.
• W3094508051 countsByYear W30945080512021 @default.
• W3094508051 countsByYear W30945080512022 @default.
• W3094508051 countsByYear W30945080512023 @default.
• W3094508051 crossrefType "journal-article" @default.
• W3094508051 hasAuthorship W3094508051A5012833454 @default.
• W3094508051 hasAuthorship W3094508051A5017845479 @default.
• W3094508051 hasAuthorship W3094508051A5031700781 @default.
• W3094508051 hasAuthorship W3094508051A5061597284 @default.
• W3094508051 hasAuthorship W3094508051A5070892221 @default.
• W3094508051 hasAuthorship W3094508051A5085416114 @default.
• W3094508051 hasConcept C101762097 @default.
• W3094508051 hasConcept C104317684 @default.
• W3094508051 hasConcept C126322002 @default.
• W3094508051 hasConcept C134018914 @default.
• W3094508051 hasConcept C134320426 @default.
• W3094508051 hasConcept C150194340 @default.
• W3094508051 hasConcept C177779419 @default.
• W3094508051 hasConcept C185592680 @default.
• W3094508051 hasConcept C203014093 @default.
• W3094508051 hasConcept C2776914184 @default.
• W3094508051 hasConcept C2778754761 @default.
• W3094508051 hasConcept C2781071285 @default.
• W3094508051 hasConcept C51911345 @default.
• W3094508051 hasConcept C55493867 @default.
• W3094508051 hasConcept C71924100 @default.
• W3094508051 hasConcept C86803240 @default.
• W3094508051 hasConcept C8891405 @default.
• W3094508051 hasConcept C95444343 @default.
• W3094508051 hasConceptScore W3094508051C101762097 @default.

• next